Substitution of brand name with generic drug appears to be safe for transplant recipients, study suggests
New research reveals that substitution of a brand name immunosuppressive drug with a generic (manufactured by Sandoz) for preventing rejection of transplanted organs appears to be safe for transplant recipients.
